Changes related to "Vinblastine (Velban)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 15:58, 20 September 2018
   
Page name:

19 September 2018

 m   22:02  Melanoma‎ (diff | hist) . . (+2,742). . Jwarner (talk | contribs) (Cisplatin, Dacarbazine +/- Carmustine {{#subobject:1c1243|Regimen=1}})

18 September 2018

 m   16:32  Melanoma‎ (diff | hist) . . (+249). . Jwarner (talk | contribs) (Ipilimumab & Nivolumab {{#subobject:517ff0|Regimen=1}})
 m   11:10  Hodgkin lymphoma‎ (diff | hist) . . (+900). . Jwarner (talk | contribs)

17 September 2018

 m   22:14  Non-small cell lung cancer‎ (diff | hist) . . (+6). . Warner-admin (talk | contribs) (Text replacement - "Subset analysis''':" to "Subgroup analysis:'''")
 m   22:14  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
 m   21:59  Melanoma‎ (diff | hist) . . (+532). . Jwarner (talk | contribs) (Pembrolizumab monotherapy {{#subobject:78d8cc|Regimen=1}})
     21:49  Hodgkin lymphoma‎ (diff | hist) . . (+3,047). . Jwarner (talk | contribs)

16 September 2018

 m   21:43  Hodgkin lymphoma‎‎ (2 changes | history) . . (+687). . [Jwarner‎ (2×)]
 m    21:43 (cur | prev) . . (+1,953). . Jwarner (talk | contribs) (CBV, then auto HSCT {{#subobject:935235|Regimen=1}})
 m    21:37 (cur | prev) . . (-1,266). . Jwarner (talk | contribs) (BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}})
 m   12:40  Breast cancer‎ (diff | hist) . . (+1,267). . Jwarner (talk | contribs) (Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}})
 m   12:34  Bladder cancer‎‎ (2 changes | history) . . (+33). . [Jwarner‎ (2×)]
 m    12:34 (cur | prev) . . (+17). . Jwarner (talk | contribs)
 m    12:31 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)

15 September 2018

 m   22:47  Hodgkin lymphoma‎‎ (2 changes | history) . . (-407). . [Jwarner‎ (2×)]
 m    22:47 (cur | prev) . . (-423). . Jwarner (talk | contribs) (References)
 m    22:40 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)
 m   11:42  Non-small cell lung cancer‎ (diff | hist) . . (+21). . Warner-admin (talk | contribs) (Regimen {{#subobject:297507|Variant=1}})

14 September 2018

 m   13:36  Non-small cell lung cancer‎ (diff | hist) . . (+280). . Jwarner (talk | contribs)
 m   11:31  Hodgkin lymphoma‎‎ (5 changes | history) . . (+2,435). . [Jwarner‎ (5×)]
 m    11:31 (cur | prev) . . (+29). . Jwarner (talk | contribs) (Investigational agents)
 m    11:22 (cur | prev) . . (+471). . Jwarner (talk | contribs) (Brentuximab vedotin monotherapy {{#subobject:c7e71|Regimen=1}})
 m    11:18 (cur | prev) . . (+1,332). . Jwarner (talk | contribs)
 m    11:08 (cur | prev) . . (+572). . Jwarner (talk | contribs)
 m    11:04 (cur | prev) . . (+31). . Jwarner (talk | contribs)

13 September 2018

 m   17:53  Breast cancer‎ (diff | hist) . . (+689). . Jwarner (talk | contribs) (CMFT {{#subobject:acff18|Regimen=1}})

12 September 2018

 m   22:39  Hodgkin lymphoma‎‎ (3 changes | history) . . (+6,717). . [Jwarner‎ (3×)]
 m    22:39 (cur | prev) . . (+30). . Jwarner (talk | contribs)
 m    22:36 (cur | prev) . . (+5,526). . Jwarner (talk | contribs)
 m    21:13 (cur | prev) . . (+1,161). . Jwarner (talk | contribs) (ABVD {{#subobject:3065be|Regimen=1}})
 m   22:12  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+45). . Jwarner (talk | contribs)